Public Alert No. 042/2024-Alert on Recall of Forty-Five Thousand (45,000) Unit of Ryaltris Nasal Spray Manufactured by Glenmark Pharmaceutical Inc
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of forty five (45,000) units of Ryaltris (olopatadine hydrochloride and mometasone furoate) nasal spray, manufactured by Glenmark Pharmaceutical Inc. The company recalled the affected lot due to defective delivery system and which is a safety concern. Ryaltris […]
